Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Not Confirmed
Not Confirmed
01-03 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Industry Trade Show
Not Confirmed
01-03 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
11 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/systimmune-inc-to-present-updated-bl-b01d1-data-in-breast-cancer-at-sabcs-congress-2024-302327993.html
26 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/systimmune-inc-announces-upcoming-presentation-at-the-2024-american-society-of-hematology-ash-annual-meeting-302315631.html
08 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/systimmune-inc-announces-fda-clearance-of-ind-application-for-bl-m17d1-in-advanced-solid-tumors-302298993.html
14 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/systimmune-inc-announces-fda-clearance-of-ind-application-for-bl-m11d1-in-relapsedrefractory-acute-myeloid-leukemia-302275098.html
09 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/systimmune-inc-to-present-new-bl-b01d1-data-in-urothelial-biliary-tract-and-esophageal-squamous-cell-carcinoma-at-esmo-congress-2024-302241865.html
23 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/systimmune-inc-announces-transition-of-chief-medical-officer-302154022.html
ABOUT THIS PAGE